Insulinlike growth factor-1 receptor: predictive factor in breast cancer patients treated with trastuzumab?
Altundag
Kadri
K
Altundag
Ozden
O
Morandi
Paolo
P
Ozcakar
Bulent
B
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D006801:Humans; D011379:Prognosis; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017526:Receptor, IGF Type 1; D000068878:Trastuzumab